Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Isosorbide mononitrate
Drug ID BADD_D01211
Description Isosorbide mononitrate is an organic nitrate with vasodilating properties. It is an anti-anginal agent that works by relaxing the smooth muscles of both arteries and veins, but but predominantly veins to reduce cardiac preload.[L11698, L11743] Isosorbide mononitrate is an active metabolite of [isosorbide dinitrate]. Like other organic nitrates, isosorbide mononitrate acts as a prodrug for its active metabolite, [nitric oxide], which mediates the therapeutic action of isosorbide mononitrate.[L11743] Isosorbide mononitrate has a longer duration of action than [nitroglycerin] due to its slow onset of absorption and metabolism.[T28] First approved by the FDA in 1991,[L11743] isosorbide mononitrate is used for the prevention and management of angina pectoris caused by coronary artery disease; however, the onset of action of orally-administered isosorbide mononitrate is not rapid enough to offset an acute anginal episode.[L11698] It is available in oral tablets generically and under the brand name ISMO and Monoket. The extended-release forms of the drug are also available generically and under the brand name Imdur.[L11743]
Indications and Usage Isosorbide mononitrate is indicated for the prevention and management of angina pectoris due to coronary artery disease. The onset of action of oral isosorbide mononitrate is not sufficiently rapid to be useful in aborting an acute anginal episode.[L11698]
Marketing Status approved
ATC Code C01DA14
DrugBank ID DB01020
KEGG ID D00630
MeSH ID C030397
PubChem ID 27661
TTD Drug ID D0YS7D
NDC Product Code 50742-176; 51407-210; 55154-7292; 59651-539; 62135-586; 62175-107; 62175-128; 71335-2194; 0615-7767; 42677-101; 13668-104; 43063-313; 53002-1570; 62175-119; 62175-129; 63187-900; 68084-592; 70518-3585; 59651-541; 62135-588; 62175-362; 63187-700; 71335-2192; 55154-7291; 62135-587; 62175-361; 70518-1485; 0615-7768; 0228-2620; 23155-519; 50742-177; 51407-209; 51655-922; 59651-540; 63629-1823; 70518-2000; 70518-2692; 70518-3081; 0228-2631; 23155-628; 50742-175; 70934-972; 71335-0037; 0904-6450; 50090-4009; 51407-208; 62175-106; 42799-960; 63629-1424; 71335-1117; 0615-8043; 0615-8044; 13668-105; 13668-106; 23155-178; 42799-958; 42799-959; 68084-591; 70518-2956; 0904-6449; 42677-307; 50090-5686; 70518-2122; 70518-3132; 42677-102
UNII LX1OH63030
Synonyms isosorbide-5-mononitrate | isosorbide mononitrate | monocinque | 5-ISMN | isosorbide-5-nitrate | Elantan | Imdur | Ismo | Olicard-retard | Mono Mac 50D | Monoket | Mononit | Olicard 40 | 5-ISMN Durules | Monizid
Chemical Information
Molecular Formula C6H9NO6
CAS Registry Number 16051-77-7
SMILES C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Affect lability19.04.01.001---
Haemorrhage24.07.01.002---
Rectal tenesmus07.03.03.001; 15.05.03.011---
Pulseless electrical activity02.03.04.0200.000070%-
Nuchal rigidity15.05.04.005; 17.05.02.006---
Dermatitis psoriasiform23.03.14.004---
Disturbance in sexual arousal19.08.04.003---
Ventricular dysfunction02.04.02.0050.000070%-
Urine output increased13.13.03.002---
Hot flush08.01.03.027; 21.02.02.001; 24.03.01.005--
Bacterial infection11.02.01.005---
Cardiac disorder02.11.01.003---
Malnutrition14.03.02.004---
Mental disorder19.07.01.002---
Decreased appetite08.01.09.028; 14.03.01.005--
Erectile dysfunction19.08.04.001; 21.03.01.007--
Ill-defined disorder08.01.03.049---
Red blood cell abnormality01.07.02.006---
Autonomic neuropathy17.05.01.009---
Hyperlipidaemia14.08.03.001--
Respiratory tract infection11.01.08.017; 22.07.07.001---
Pharyngeal disorder22.04.05.007---
Skin mass23.07.04.014---
Anorectal discomfort07.03.03.003---
Candida infection11.03.03.021--
Drug ineffective for unapproved indication08.06.01.038; 12.09.02.0020.000105%-
The 8th Page    First    Pre   8    Total 8 Pages